4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-23-011777
General Counsel and Secretary gave up 1,950 shares (to pay taxes)
- General Counsel and Secretary acquired 3,825 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2023-02-18 | Option exercise | +3,825 | 54,016 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2023-02-21 | Shares withheld for taxes | −1,950 | $48.26 | $94,107 | 52,066 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2023-02-18 | Option exercise · Restricted Stock Units | −3,825 | 11,475 | D | ||
Loading xslF345X03/doc4.xml…